144 related articles for article (PubMed ID: 11389188)
1. Tau-66: evidence for a novel tau conformation in Alzheimer's disease.
Ghoshal N; García-Sierra F; Fu Y; Beckett LA; Mufson EJ; Kuret J; Berry RW; Binder LI
J Neurochem; 2001 Jun; 77(5):1372-85. PubMed ID: 11389188
[TBL] [Abstract][Full Text] [Related]
2. DC11: a novel monoclonal antibody revealing Alzheimer's disease-specific tau epitope.
Vechterova L; Kontsekova E; Zilka N; Ferencik M; Ravid R; Novak M
Neuroreport; 2003 Jan; 14(1):87-91. PubMed ID: 12544837
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.
Kondratick CM; Vandré DD
J Neurochem; 1996 Dec; 67(6):2405-16. PubMed ID: 8931473
[TBL] [Abstract][Full Text] [Related]
4. Conformational change as one of the earliest alterations of tau in Alzheimer's disease.
Weaver CL; Espinoza M; Kress Y; Davies P
Neurobiol Aging; 2000; 21(5):719-27. PubMed ID: 11016541
[TBL] [Abstract][Full Text] [Related]
5. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease.
Jicha GA; Lane E; Vincent I; Otvos L; Hoffmann R; Davies P
J Neurochem; 1997 Nov; 69(5):2087-95. PubMed ID: 9349554
[TBL] [Abstract][Full Text] [Related]
6. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.
Guillozet-Bongaarts AL; Garcia-Sierra F; Reynolds MR; Horowitz PM; Fu Y; Wang T; Cahill ME; Bigio EH; Berry RW; Binder LI
Neurobiol Aging; 2005 Jul; 26(7):1015-22. PubMed ID: 15748781
[TBL] [Abstract][Full Text] [Related]
7. A possible link between astrocyte activation and tau nitration in Alzheimer's disease.
Reyes JF; Reynolds MR; Horowitz PM; Fu Y; Guillozet-Bongaarts AL; Berry R; Binder LI
Neurobiol Dis; 2008 Aug; 31(2):198-208. PubMed ID: 18562203
[TBL] [Abstract][Full Text] [Related]
8. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies.
Combs B; Hamel C; Kanaan NM
Neurobiol Dis; 2016 Oct; 94():18-31. PubMed ID: 27260838
[TBL] [Abstract][Full Text] [Related]
9. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
[TBL] [Abstract][Full Text] [Related]
10. Tau epitope display in progressive supranuclear palsy and corticobasal degeneration.
Berry RW; Sweet AP; Clark FA; Lagalwar S; Lapin BR; Wang T; Topgi S; Guillozet-Bongaarts AL; Cochran EJ; Bigio EH; Binder LI
J Neurocytol; 2004 May; 33(3):287-95. PubMed ID: 15475684
[TBL] [Abstract][Full Text] [Related]
11. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
[TBL] [Abstract][Full Text] [Related]
12. Visualization of newly deposited tau in neurofibrillary tangles and neuropil threads.
Miyasaka T; Watanabe A; Saito Y; Murayama S; Mann DM; Yamazaki M; Ravid R; Morishima-Kawashima M; Nagashima K; Ihara Y
J Neuropathol Exp Neurol; 2005 Aug; 64(8):665-74. PubMed ID: 16106214
[TBL] [Abstract][Full Text] [Related]
13. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
Su JH; Cummings BJ; Cotman CW
Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
[TBL] [Abstract][Full Text] [Related]
14. A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles.
Brici D; Götz J; Nisbet RM
J Alzheimers Dis; 2018; 61(3):899-905. PubMed ID: 29332046
[TBL] [Abstract][Full Text] [Related]
15. First insert of tau protein is present in all stages of tau pathology in Alzheimer's disease.
Soltys K; Rolkova G; Vechterova L; Filipcik P; Zilka N; Kontsekova E; Novak M
Neuroreport; 2005 Oct; 16(15):1677-81. PubMed ID: 16189476
[TBL] [Abstract][Full Text] [Related]
16. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease.
Horowitz PM; Patterson KR; Guillozet-Bongaarts AL; Reynolds MR; Carroll CA; Weintraub ST; Bennett DA; Cryns VL; Berry RW; Binder LI
J Neurosci; 2004 Sep; 24(36):7895-902. PubMed ID: 15356202
[TBL] [Abstract][Full Text] [Related]
17. Neurofilament monoclonal antibodies RT97 and 8D8 recognize different modified epitopes in paired helical filament-tau in Alzheimer's disease.
Brion JP; Couck AM; Robertson J; Loviny TL; Anderton BH
J Neurochem; 1993 Apr; 60(4):1372-82. PubMed ID: 7681101
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's-disease-associated conformation of intrinsically disordered tau protein studied by intrinsically disordered protein liquid-phase competitive enzyme-linked immunosorbent assay.
Skrabana R; Skrabanova-Khuebachova M; Kontsek P; Novak M
Anal Biochem; 2006 Dec; 359(2):230-7. PubMed ID: 17081491
[TBL] [Abstract][Full Text] [Related]
19. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau.
Jicha GA; Bowser R; Kazam IG; Davies P
J Neurosci Res; 1997 Apr; 48(2):128-32. PubMed ID: 9130141
[TBL] [Abstract][Full Text] [Related]
20. Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease.
Jicha GA; Berenfeld B; Davies P
J Neurosci Res; 1999 Mar; 55(6):713-23. PubMed ID: 10220112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
